Predictive and Prognostic Value of sPRR in Patients with Primary Epithelial Ovarian Cancer

Table 1

Patient’s clinical and pathologic characteristics.

Age in years at diagnosis	Median 60 (range 28–92)
Follow-up period in months	Mean 44.5 (range 1–114)
Parameters		%
	197 patients
Histology
Serous	183	92.9
Endometrioid	1	0.5
Clear cell tumour	1	0.5
Mixed	4	2.0
Others	8	4.1
FIGO
I	5	2.5
II	11	5.6
III	135	68.5
IV	46	23.4
Histological grading
I	8	4.1
II	49	24.9
III	140	71.0
Volume of ascites
No ascites	47	23.9
<500 mL	77	39.1
>500 mL	73	37.0
Peritoneal carcinomatosis
Present	174	88.3
Residual tumour mass
No residual tumour mass	103	52.3
<0,5 cm	34	17.3
<1 cm	30	15.2
1-2 cm	6	3.0
>2 cm	22	11.2
No tumour	2	1.0
Response to platinum-based chemotherapy
Platinum sensitive	116	58.9
Platinum resistant	55	27.9
No platinum chemo	26	13.2